Biotech ETFs in Focus episode artwork

EPISODE · Mar 8, 2016 · 55 MIN

Biotech ETFs in Focus

from ETF Prime

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.  Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.

Episode metadata supplied by the publisher feed · Published Mar 8, 2016

NOW PLAYING

Biotech ETFs in Focus

0:00 55:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of ETF Prime?

This episode is 55 minutes long.

When was this ETF Prime episode published?

This episode was published on March 8, 2016.

What is this episode about?

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.  Nate and Conor also explain why ETFs can be an excellent...

Can I download this ETF Prime episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!